Asthma & COPD Treatment Flashcards

1
Q

What is 1st line tx for asthma according to GINA 2019?

A

reliever
low dose budesonide/formoterol PRN (provides relief just as quickly as SABA)
alt: SABA and low dose ICS at the same time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are 2nd-5th line tx options for asthma according to GINA 2019?

A

2nd line: low dose ICS prn or daily alt LTRA
3rd line: daily low dose ICS/LABA alt ICS+LTRA
4rth line: daily med dose ICS/LABA alt +/- tiotropium or LTRA
5th line: daily high dose ICS/LABA alt +/- OCS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ICS AE

A

Sore mouth, sore throat, dysphonia, oral thrush (can be reduced by rinsing mouth or using spacer).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SABA/LABA AE

A

Nervousness, tremor, tachycardia, palpitations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SAMA/LAMA AE

A

Dry mouth, metallic taste; mydriasis and glaucoma if released into eye.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is used to treat asthma in children?

A

SABA PRN, ICS+/-LABA maintenance, tiotropium adjunct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is used to treat COPD in patients with:
0-1 exacerbations
no hospitalizations
mMRC 0-1

A

SABA or SAMA PRN

GOLD Group A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is used to treat COPD in patients with:
0-1 exacerbations
no hospitalizations
mMRC 2-4

A

LAMA or LABA

GOLD Group B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is used to treat COPD in patients with:
>2 exacerbations
hospitalizations
mMRC 0-1

A

LAMA

GOLD Group C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is used to treat COPD in patients with:
>2 exacerbations
hospitalizations
mMRC 2-4

A

LAMA or LAMA/LABA or ICS/LABA or ICS/LAMA/LABA

GOLD Group D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are tx options for COPD patients symptomatic despite ICS/LAMA/LABA?

A

theophyline
roflumilast
n-acetylcysteine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are tx options for asthma patients symptomatic despite optimizing inhalers?

A
montelukast
theophyline
sodium cromoglycate 
omalizumab
mepolizumab, benralizuman, reslizumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are asthma exacerbations treated?

A

SAMA/SABA
PO/IV Corticosteroids (Prednisone x7-14d)
NO antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How are COPD exacerbations treated?

A

SAMA/SABA
Corticosteroids (Prednisone x5d)
Antibiotics if on ventilator or 2 of: dyspnea, sputum, purulence: Amox, Doxy, Septra (consider others if >4 exacerabations/yr, may use azithro preventatively)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mMRC dyspnea scale

A
dyspnea with
0-strenuous exercise
1-hurrying or walking uphill
2-walking slower than normal
3-walking 100m/few min
4-dressing, unable to leave house
used for COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drugs in each class used in asthma

A
SABA: salbutamol, terbutaline
SAMA: ipratropium
LABA: formoterol, salmeterol, vilanterol
LAMA: tiotropium
ICS: beclomethasone, budesonide, ciclesonide, fluticasone, mometasone
17
Q

Drugs in each class used in COPD

A

SABA: salbutamol, terbutaline
SAMA: ipratropium
LABA: formoterol, INDACATEROL
LAMA: tiotropium, GLYCOPYRRONIUM, ACLIDINIUM, UMECLIDINIUM
ICS: beclomethasone, budesonide, ciclesonide, fluticasone, mometasone

18
Q

What are the 4 Qs in the GINA assessment for asthma control?

A
In the past 4 weeks have you had:
-daytime sx more than 2/wk
-night waking due to sx
-reliever needed more than 2/wk
-activity limitation due to sx
0=well controlled
1-2=partly controlled
3-4=uncontrolled
19
Q

A well controlled asthmatic should only need how many canisters of SABA per year

A

1-2 salbutamol MDI

2-4 terbutaline DPI

20
Q

once daily corticosteroids should be dosed at what time in children

A

in the morning to minimize HPA suppression (sx include growth suppression)